학술논문
Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia
Document Type
Article
Author
Hill, Brian T.; Ma, Shuo; Zent, Clive S.; Baran, Andrea M.; Wallace, Danielle S.; Advani, Anjali; Winter, Allison; Winter, Jane; Gordan, Leo; Karmali, Reem; Liesveld, Jane L.; Mulford, Deborah A.; Rowland, Chris; Bui, Andrew; Sportelli, Peter; Miskin, Hari P.; Weiss, Michael S.; Friedberg, Jonathan W.; Barr, Paul M.
Source
In Blood Advances 23 January 2024 8(2):378-387
Subject
Language
ISSN
2473-9529